Opportunity Information: Apply for RFA 663 12 000007
Apply for RFA 663 12 000007
- The Ethiopia USAID Addis Ababa in the health sector is offering a public funding opportunity titled "Strengthening Ethiopias Urban Health Program (SEUHP)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Sep 17, 2012 and posted on Sep 17, 2012.
- Applicants must submit their applications by Oct 16, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $20,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $20,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Strengthening Ethiopias Urban Health Program (SEUHP) grant opportunity (Funding Opportunity Number RFA 663 12 000007) was a USAID Ethiopia discretionary funding opportunity released through the USAID mission in Addis Ababa to support the Government of Ethiopias (GOE) urban health extension program. The central aim was to improve the quality and effectiveness of health services delivered at the community level in urban settings, with a strong emphasis on making front-line services more consistent, better supervised, and more responsive to the practical health needs found in towns and cities. In addition to improving service quality, the opportunity focused on strengthening referral linkages, meaning the program intended to help communities connect more reliably to higher-level health facilities when cases could not be handled at the community level, reducing gaps where clients might otherwise be lost between community outreach and facility-based care.
A major component of the opportunity was capacity building for Regional Health Bureaus (RHBs). This reflects a systems-strengthening approach rather than a narrow service-delivery project, with the expectation that applicants would help build institutional and technical capabilities within regional government health structures so they could plan, manage, supervise, and sustain improvements in urban health programming. Alongside the health sector focus, SEUHP also highlighted inter-sectoral collaboration to address urban health challenges, signaling that urban health outcomes are shaped by factors that often sit outside clinics and health posts, such as sanitation, water, education, housing, and municipal services. The intent was to encourage coordination across sectors so that urban health extension work could better address the underlying drivers of illness and barriers to care in dense urban environments.
The funding instrument type was a Cooperative Agreement, which typically means USAID anticipated substantial involvement during implementation, including ongoing collaboration on technical direction, work planning, and performance management. The activity category was Health, and the CFDA number listed was 98.001 (USAID Foreign Assistance for Programs Overseas). The opportunity anticipated a single award (Expected Awards: 1) with an estimated total funding amount of USD 20,000,000, and both the award ceiling and floor were set at USD 20,000,000, indicating USAID planned one award at that fixed total amount rather than a range of possible award sizes. Cost sharing or matching was required, meaning the recipient would need to contribute a portion of resources (cash and/or allowable in-kind support) as part of the overall project effort, consistent with the specific terms described in the full announcement.
Eligibility was listed as unrestricted, open to any type of entity, subject to any clarifications in the full text under the eligibility section. The announcement was posted on September 17, 2012, with an original and final closing date of October 16, 2012, and an archive date of November 15, 2012, indicating it is no longer open. Additional details and the full announcement were available via Grants.gov, and the contact listed for access issues was Tesfaye Wolde, Acquisition and Assistance Specialist, reachable by phone at 2022166203 or 251 11 1306019, with an email domain noted as usaid.gov.
Frequently Asked Questions (FAQs)
What is the Strengthening Ethiopias Urban Health Program (SEUHP) grant opportunity?
SEUHP was a USAID Ethiopia discretionary funding opportunity released through the USAID mission in Addis Ababa to support the Government of Ethiopias (GOE) urban health extension program. The opportunity was focused on improving community-level health services in urban settings.
What is the Funding Opportunity Number for SEUHP?
The Funding Opportunity Number was RFA 663 12 000007.
Which organization issued this funding opportunity?
The opportunity was issued by USAID Ethiopia through the USAID mission in Addis Ababa.
What is the main aim of this opportunity?
The central aim was to improve the quality and effectiveness of health services delivered at the community level in urban areas, with an emphasis on making front-line services more consistent, better supervised, and more responsive to practical health needs in towns and cities.
What types of improvements to service delivery were emphasized?
The opportunity emphasized improving service quality at the front line, including greater consistency in services, stronger supervision, and improved responsiveness to real-world urban community health needs.
Did the opportunity address referrals to higher-level health facilities?
Yes. A stated focus was strengthening referral linkages so communities could connect more reliably to higher-level health facilities when cases could not be handled at the community level, reducing gaps between community outreach and facility-based care.
Was capacity building part of the program design?
Yes. A major component was capacity building for Regional Health Bureaus (RHBs), reflecting a systems-strengthening approach intended to build institutional and technical capabilities within regional government health structures.
Which institutions were specifically highlighted for capacity building?
The opportunity specifically highlighted Regional Health Bureaus (RHBs) as key institutions for capacity building.
What kinds of capabilities within Regional Health Bureaus were intended to be strengthened?
The program expectation was that applicants would help strengthen RHBs ability to plan, manage, supervise, and sustain improvements in urban health programming.
Did SEUHP encourage collaboration beyond the health sector?
Yes. SEUHP highlighted inter-sectoral collaboration to address urban health challenges, recognizing that outcomes are influenced by factors beyond clinical services.
What non-health sectors or factors were mentioned as relevant to urban health outcomes?
The opportunity pointed to factors such as sanitation, water, education, housing, and municipal services as areas that shape urban health outcomes and may require coordination with the health extension effort.
What was the funding instrument type?
The funding instrument type was a Cooperative Agreement.
What does it mean that the award was a Cooperative Agreement?
Based on the opportunity description, it indicated USAID anticipated substantial involvement during implementation, including ongoing collaboration on technical direction, work planning, and performance management.
What was the activity category for this opportunity?
The activity category was Health.
What CFDA number was listed?
The CFDA number listed was 98.001 (USAID Foreign Assistance for Programs Overseas).
How many awards were anticipated under this opportunity?
The opportunity anticipated a single award (Expected Awards: 1).
What was the estimated total funding amount?
The estimated total funding amount was USD 20,000,000.
What were the award ceiling and award floor?
Both the award ceiling and the award floor were USD 20,000,000, indicating USAID planned one award at a fixed total amount rather than a range of possible award sizes.
Was cost sharing or matching required?
Yes. Cost sharing or matching was required, meaning the recipient would need to contribute a portion of resources (cash and/or allowable in-kind support) as part of the overall project effort, consistent with the specific terms in the full announcement.
Who was eligible to apply?
Eligibility was listed as unrestricted, open to any type of entity, subject to any clarifications in the full text under the eligibility section.
When was the opportunity posted?
The announcement was posted on September 17, 2012.
What was the closing date to apply?
The original and final closing date was October 16, 2012.
Is this opportunity still open?
No. The archive date was November 15, 2012, indicating the opportunity is no longer open.
Where could applicants find the full announcement?
Additional details and the full announcement were available via Grants.gov.
Who was listed as the contact for access issues, and how could they be reached?
The contact listed for access issues was Tesfaye Wolde, Acquisition and Assistance Specialist. The phone numbers provided were 2022166203 and 251 11 1306019. The email was noted as using the usaid.gov domain.
Browse more opportunities from the same category: Health
Next opportunity: Collaborative Research in Structural Sciences
Previous opportunity: Research Grants (Generic)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA 663 12 000007
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA 663 12 000007) also looked into and applied for these:
| Funding Opportunity |
|---|
| Perinatal Hepatitis B Prevention Program, Supplemental Evaluation Projects (PHBPP SEP) Apply for CDC RFA PS13 1307 Funding Number: CDC RFA PS13 1307 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| HIV Early Intervention Services (EIS) Program Existing Geographic Service Areas (EISEGA) Apply for HRSA 13 252 Funding Number: HRSA 13 252 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Health Media Project (HMP), Kenya Apply for RFA 615 12 000006 Funding Number: RFA 615 12 000006 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $8,000,000 |
| Immunity in the Elderly (R01) Apply for RFA AI 12 038 Funding Number: RFA AI 12 038 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Ancillary Studies in Clinical Trials (R01) Apply for RFA HL 14 004 Funding Number: RFA HL 14 004 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21) Apply for PA 12 292 Funding Number: PA 12 292 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01) Apply for PA 12 291 Funding Number: PA 12 291 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Care Grant Program Part B Apply for HRSA 13 158 Funding Number: HRSA 13 158 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NHLBI Clinical Trial Pilot Studies (R34) Apply for PAR 13 002 Funding Number: PAR 13 002 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Functional Assays to Screen Genomic Hits (R21/R33) Apply for RFA HL 13 027 Funding Number: RFA HL 13 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Clinical Scientist Development Award in Aging (K08) Apply for RFA AG 13 011 Funding Number: RFA AG 13 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Patient Oriented Research Career Development Award in Aging (K23) Apply for RFA AG 13 012 Funding Number: RFA AG 13 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epigenetic Inheritance and Transgenerational Effects of Alcohol (R01) Apply for PA 13 003 Funding Number: PA 13 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epigenetic Inheritance and Transgenerational Effects of Alcohol (R21) Apply for PA 13 004 Funding Number: PA 13 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Limited Competition Continuation of the National Institute on Aging Multicenter Clinical Trial The LIFE Study (U01) Apply for PAR 13 001 Funding Number: PAR 13 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| TECHNICAL ASSISTANCE AND SUPPORT OF HIV PREVENTION, CARE TREATMENT PROGRAMS AND OTHER INFECTIOUS DISEASES THAT IMPACT HIV INFECTED PATIENTS IN SUPPORT OF THE PRESIDENTS EMERGENCY PLAN FOR AIDS RELIEF Apply for CDC RFA PS09 9040401SUPP13 Funding Number: CDC RFA PS09 9040401SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $635,768 |
| Presidents Malaria Initiative Apply for USAID GUINEA RFA 675 13 000001 Funding Number: USAID GUINEA RFA 675 13 000001 Agency: Senegal USAID Dakar Category: Health Funding Amount: $18,428,129 |
| Interdisciplinary Approach to Identification and Validation of Novel Therapeutic Targets for Alzheimers Disease (R01) Apply for RFA AG 13 013 Funding Number: RFA AG 13 013 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Alzheimers Disease Prevention Trials (R01) Apply for RFA AG 13 015 Funding Number: RFA AG 13 015 Agency: National Institutes of Health Category: Health Funding Amount: $4,500,000 |
| Alzheimers Disease Phase I Clinical Trials (R01) Apply for RFA AG 13 016 Funding Number: RFA AG 13 016 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA 663 12 000007", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.